Phenotype variability and natural history of X-linked myopathy with excessive autophagy
- 22 March 2024
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (7) , 4008-4018
Abstract
Objective X-linked myopathy with excessive autophagy (XMEA) linked to the VMA21 gene leads to autophagy failure with progressive vacuolation and atrophy of skeletal muscles. Current knowledge of this rare disease is limited. Our objective was to define the clinical, radiological, and natural history of XMEA. Methods We conducted a retrospective study collecting clinical, genetic, muscle imaging, and biopsy data of XMEA patients followed in France and reviewed the literature for additional cases. Results Eighteen males had genetically confirmed XMEA in France, carrying four different VMA21 variants. Mean age at disease onset was 9.4 ± 9.9 (range 1–40) years. In 14/18 patients (77.8%), onset occurred during childhood (< 15 years); however in four patients, the disease started in adulthood. Patients had anterior and medial compartment thigh muscle weakness, distal contractures (56.3%), elevated CK levels (1287.9 ± 757.8 U/l) and autophagic vacuoles with sarcolemmal features on muscle histopathology. Muscle MRI (n = 10) showed a characteristic pattern of lower limb muscle involvement. In 11 patients, outcome measures were available for an average follow-up period of 10.6 ± 9.8 years and six of them show disease progression. Mean change of functional outcomes was 0.5 ± 1.2 points for Brooke and 2.2 ± 2.5 points for Vignos score, 7/16 patients (43.8%) needed a walking aid and 3/16 (18.8%) were wheelchair-bound (median age of 40 years old, range 39–48). The variant c.164-7 T > G was associated with a later onset of symptoms. Respiratory insufficiency was common (57.1%) but cardiac involvement rare (12.5%). Interpretation XMEA has variable age of onset, but a characteristic clinical, histopathological, and muscle imaging presentation, guiding the diagnosis. Although slowly, motor disability progresses with time, and relevant genotype–phenotype correlations will help design future clinical trials.Keywords
This publication has 26 references indexed in Scilit:
- X-linked myopathy with excessive autophagy due to a mutation in VMA21 gene: the first case in ChinaNeurological Sciences, 2022
- Muscle magnetic resonance imaging abnormalities in X‐linked myopathy with excessive autophagyMuscle & Nerve, 2015
- X-linked myopathy with excessive autophagy: a failure of self-eatingActa Neuropathologica, 2015
- Late adult‐onset of X‐linked myopathy with excessive autophagyMuscle & Nerve, 2014
- Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal diseaseEMBO Molecular Medicine, 2013
- VMA21 deficiency prevents vacuolar ATPase assembly and causes autophagic vacuolar myopathyActa Neuropathologica, 2013
- The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findingsClinical Neurophysiology, 2011
- Muscle MRI in inherited neuromuscular disorders: Past, present, and futureJournal of Magnetic Resonance Imaging, 2007
- X‐linked vacuolated myopathy: Complement membrane attack complex on surface membrane of injured muscle fibersAnnals of Neurology, 1995
- X‐Linked myopathy with excessive autophagy: A new hereditary muscle diseaseAnnals of Neurology, 1988